ARTICLE | Clinical News
Ameluz regulatory update
July 27, 2015 7:00 AM UTC
Biofrontera submitted an NDA to FDA for Ameluz and BF-RhodoLED to treat actinic keratosis. Ameluz is a photodynamic therapy comprising nanoemulsion BF-200 with 5-aminolevulinic acid (ALA) photosensiti...